Compounds > di-tert-butylperoxy-3,3,5-trimethylcyclohexane peroxide
Page last updated: 2024-12-07

di-tert-butylperoxy-3,3,5-trimethylcyclohexane peroxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

di-tert-butylperoxy-3,3,5-trimethylcyclohexane peroxide: widely used as a source of free radicals in the hardening of unsaturated polyester resins and the polymerization of styrene; structure in second source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID93038
SCHEMBL ID21420
MeSH IDM0184332

Synonyms (41)

Synonym
1,1-bis(tert-butylperoxy)-3,3,5-trimethylcyclohexane
6731-36-8
1,1-bis[(1,1-dimethylethyl)peroxy]-3,3,5-trimethylcyclohexane
di-tert-butyl 3,3,5-trimethylcyclohexylidene diperoxide
luperox 231
peroxide, (3,3,5-trimethylcyclohexylidene)bis(tert-butyl)
trigonox 29/40
varox 231xl
trigonox 29b75
brn 5932965
trigonox 29b50
peroxide, (3,3,5-trimethylcyclohexylidene)bis((1,1-dimethylethyl)
1,1-bis(t-butylperoxy)-3,3,5-trimethylcyclohexane
luperco 231g
perhexa 3m
einecs 229-782-3
luperco 231xlp
luperco 231xl
lupersol 231
trigonox 29/40mb
trigonox 29
di-tert-butylperoxy-3,3,5-trimethylcyclohexane peroxide
trigonox 29c75
luperox(r) 231, 1,1-bis(tert-butylperoxy)-3,3,5-trimethylcyclohexane, 92%
ccris 6844
1,1-bis(tert-butyldioxy)-3,3,5-trimethylcyclohexane
A835707
1,1-bis(tert-butylperoxy)-3,3,5-trimethyl-cyclohexane
ec 229-782-3
peroxide, 1,1'-(3,3,5-trimethylcyclohexylidene)bis(2-(1,1-dimethylethyl)
FT-0606071
AKOS015913687
peroxide, 1,1'-(3,3,5-trimethylcyclohexylidene)bis[2-(1,1-dimethylethyl)
SCHEMBL21420
1,1-bis(tert.-butyl peroxy)-3,3,5-trimethyl cyclohexane
1,1-bis(t-butylperoxy)-3,3,5-trimethyl-cyclohexane
1,1-bis (tert-butylperoxi)-3,3,5 trimethylcyclohexane
NALFRYPTRXKZPN-UHFFFAOYSA-N
1,1-di-(tert-butylperoxy)-3,3,5-trimethylcyclohexane
DTXSID4020165
Q3375552
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (23.08)18.2507
2000's3 (23.08)29.6817
2010's3 (23.08)24.3611
2020's4 (30.77)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.11 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
bumetanide
[no description available]		2.1110amino acid;
benzoic acids;
sulfonamide		diuretic;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
deet
N,N-diethyl-m-toluamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of m-toluic acid with the nitrogen of diethylamine. First developed by the U.S. Army in 1946 for use by military personnel in insect-infested areas, it is the most widely used insect repellent worldwide.		2.1110benzamides;
monocarboxylic acid amide		environmental contaminant;
insect repellent;
xenobiotic
2,4-di-tert-butylphenol
2,4-di-tert-butylphenol: structure given in first source. 2,4-di-tert-butylphenol : A member of the class of phenols carrying two tert-butyl substituents at positions 2 and 4.		2.4110alkylbenzene;
phenols		antioxidant;
bacterial metabolite;
marine metabolite
butylphen
butylphen: irritant; structure. 4-tert-butylphenol : A member of the class of phenols that is phenol substituted with a tert-butyl group at position 4.		2.920phenolsallergen
di-tert-butyl peroxide
tert-butyl peroxide: structure in first source		2.610
alkenes
[no description available]		2.0810
gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate: RN refers to Na salt		2.1110
2-oxindole
2-oxindole: RN given refers to parent cpd; structure. indolin-2-one : An indolinone carrying an oxo group at position 2.		2.0810gamma-lactam;
indolinone
gadolinium dtpa
Gadolinium DTPA: A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see PENTETIC ACID), that is given to enhance the image in cranial and spinal MRIs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)		2.1110gadolinium coordination entityMRI contrast agent
chitosan
[no description available]		2.0210
ConditionIndicatedRelationship StrengthStudiesTrials
Cancer of Colon
[description not available]		02.1110
Angiogenesis, Pathologic
[description not available]		02.1110
Colonic Neoplasms
Tumors or cancer of the COLON.		02.1110
Benign Neoplasms
[description not available]		01.9810
Anemia
A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.		01.9810
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.		01.9810
Weight Gain
Increase in BODY WEIGHT over existing weight.		01.9810
Body Weight
The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.		01.9810